These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12407448)

  • 1. Enhanced uptake of ifosfamide into GH3 prolactinomas with hypercapnic hyperoxic gases monitored in vivo by (31)P MRS.
    Rodrigues LM; Robinson SP; McSheehy PM; Stubbs M; Griffiths JR
    Neoplasia; 2002; 4(6):539-43. PubMed ID: 12407448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo detection of ifosfamide by 31P-MRS in rat tumours: increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas.
    Rodrigues LM; Maxwell RJ; McSheehy PM; Pinkerton CR; Robinson SP; Stubbs M; Griffiths JR
    Br J Cancer; 1997; 75(1):62-8. PubMed ID: 9000599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumours.
    McSheehy PM; Port RE; Rodrigues LM; Robinson SP; Stubbs M; van der Borns K; Peters GJ; Judson IR; Leach MO; Griffiths JR
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):117-28. PubMed ID: 15592719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors.
    Rodrigues LM; Howe FA; Griffiths JR; Robinson SP
    J Magn Reson Imaging; 2004 Apr; 19(4):482-8. PubMed ID: 15065173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging.
    Robinson SP; Howe FA; Griffiths JR
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):855-9. PubMed ID: 7591894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging.
    Robinson SP; Collingridge DR; Howe FA; Rodrigues LM; Chaplin DJ; Griffiths JR
    NMR Biomed; 1999 Apr; 12(2):98-106. PubMed ID: 10392806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of carbogen breathing and acetazolamide on optic disc PO2.
    Petropoulos IK; Pournaras JA; Munoz JL; Pournaras CJ
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4139-46. PubMed ID: 16249491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal tissue quantitative T1 and T2* MRI relaxation time responses to hypercapnic and hyperoxic gases.
    Winter JD; Estrada M; Cheng HL
    Acad Radiol; 2011 Sep; 18(9):1159-67. PubMed ID: 21704536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental retinal vein occlusion: effect of acetazolamide and carbogen (95% O2/5% CO2) on preretinal PO2.
    Pournaras JA; Petropoulos IK; Munoz JL; Pournaras CJ
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3669-77. PubMed ID: 15452075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of different levels of hypercapnic hyperoxia on tumour R(2)* and arterial blood gases.
    Robinson SP; Rodrigues LM; Howe FA; Stubbs M; Griffiths JR
    Magn Reson Imaging; 2001 Feb; 19(2):161-6. PubMed ID: 11358653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative MRI assessment of VX2 tumour oxygenation changes in response to hyperoxia and hypercapnia.
    Winter JD; Akens MK; Cheng HL
    Phys Med Biol; 2011 Mar; 56(5):1225-42. PubMed ID: 21285489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of tumour perfusion and oxygenation monitored by gradient recalled echo MRI and 31P MRS.
    Howe FA; Robinson SP; Griffiths JR
    NMR Biomed; 1996 Aug; 9(5):208-16. PubMed ID: 9068002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
    Teicher BA; Holden SA; Jacobs JL
    Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo determination of tumor oxygenation during growth and in response to carbogen breathing using 15C5-loaded alginate capsules as fluorine-19 magnetic resonance imaging oxygen sensors.
    Nöth U; Rodrigues LM; Robinson SP; Jork A; Zimmermann U; Newell B; Griffiths JR
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):909-19. PubMed ID: 15465209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of systemic nitric oxide synthase inhibition on optic disc oxygen partial pressure in normoxia and in hypercapnia.
    Petropoulos IK; Pournaras JA; Stangos AN; Pournaras CJ
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):378-84. PubMed ID: 18676634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BOLD MRI response to hypercapnic hyperoxia in patients with meningiomas: correlation with Gadolinium-DTPA uptake rate.
    Rijpkema M; Schuuring J; Bernsen PL; Bernsen HJ; Kaanders JH; van der Kogel AJ; Heerschap A
    Magn Reson Imaging; 2004 Jul; 22(6):761-7. PubMed ID: 15234444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow and oxygenation dependent (FLOOD) contrast MR imaging to monitor the response of rat tumors to carbogen breathing.
    Howe FA; Robinson SP; Rodrigues LM; Griffiths JR
    Magn Reson Imaging; 1999 Nov; 17(9):1307-18. PubMed ID: 10576716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR; Overgaard J
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified oxygen mask to induce target levels of hyperoxia and hypercarbia during radiotherapy: a more effective alternative to carbogen.
    Prisman E; Slessarev M; Azami T; Nayot D; Milosevic M; Fisher J
    Int J Radiat Biol; 2007 Jul; 83(7):457-62. PubMed ID: 17538795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
    Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
    Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.